We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 6.99%
2 Financials 5.48%
3 Industrials 4.89%
4 Consumer Discretionary 4.88%
5 Healthcare 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYMX
6926
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$83K ﹤0.01%
21,600
-24,100
-53% -$91.4K
IPI icon
6927
CALL
Intrepid Potash
IPI
$469M
$82K ﹤0.01%
1,870
-210
-10% -$7.08K
NSLR
6928
Neostellar Capital Corp
NSLR
$254M
$82K ﹤0.01%
17,956
+5,378
+43% +$20.5K
MTEM
6929
DELISTED
Molecular Templates, Inc.
MTEM
$81K ﹤0.01%
+776
New +$67K
ANFI
6930
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$81K ﹤0.01%
13,388
-8,123
-38% -$46.4K
VEON icon
6931
CALL
VEON
VEON
$3.95B
$80K ﹤0.01%
764
+248
+48% +$25.3K
WPRT
6932
Westport Fuel Systems
WPRT
$35.7M
$79K ﹤0.01%
2,403
-2,548
-51% -$57.3K
DMK
6933
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$79K ﹤0.01%
216
-645
-75% -$229K
PDLI
6934
CALL
DELISTED
PDL BioPharma, Inc.
PDLI
$79K ﹤0.01%
23,300
+2,400
+11% +$6.67K
SPHS
6935
DELISTED
Sophiris Bio, Inc.
SPHS
$79K ﹤0.01%
+36,721
New +$76.1K
AMSC icon
6936
PUT
American Superconductor
AMSC
$1.59B
$78K ﹤0.01%
17,100
+1,200
+8% +$4.66K
DNN icon
6937
Denison Mines
DNN
$2.91B
$78K ﹤0.01%
+170,031
New +$80.2K
CCEC
6938
PUT
Capital Clean Energy Carriers
CCEC
$1.35B
$78K ﹤0.01%
+3,171
New +$80.4K
ATCO
6939
CALL
DELISTED
Atlas Corp.
ATCO
$78K ﹤0.01%
+11,000
New +$75.7K
NPTN
6940
PUT
DELISTED
NEOPHOTONICS CORP
NPTN
$78K ﹤0.01%
14,000
-500
-3% -$3.37K
DMK
6941
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$77K ﹤0.01%
210
-84
-29% -$29.8K
CXDC
6942
DELISTED
China XD Plastics Company Limited
CXDC
$77K ﹤0.01%
+16,420
New +$76.3K
AREX
6943
CALL
DELISTED
Approach Resources Inc.
AREX
$77K ﹤0.01%
30,800
-19,200
-38% -$52.8K
INO icon
6944
PUT
Inovio Pharmaceuticals
INO
$69M
$76K ﹤0.01%
1,000
-17
-2% -$1.26K
AUPH icon
6945
Aurinia Pharmaceuticals
AUPH
$2.04B
$75K ﹤0.01%
11,900
-61,370
-84% -$387K
GER
6946
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$75K ﹤0.01%
1,204
-662
-35% -$41.6K
ABEV icon
6947
PUT
Ambev
ABEV
$46.4B
$74K ﹤0.01%
11,300
-17,400
-61% -$108K
DNR
6948
CALL
DELISTED
Denbury Resources, Inc.
DNR
$74K ﹤0.01%
55,000
+16,500
+43% +$21.5K
OXSQ icon
6949
Oxford Square Capital
OXSQ
$157M
$73K ﹤0.01%
+10,654
New +$71.5K
GV
6950
CALL
DELISTED
Goldfield Corporation
GV
$73K ﹤0.01%
+11,600
New +$59.1K

Similar funds

Citadel Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Citadel Advisors held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citadel Advisors's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.1% a quarter earlier, followed by Financials and Industrials.

  • Citadel Advisors's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Citadel Advisors added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Citadel Advisors's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Citadel Advisors fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Citadel Advisors's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Citadel Advisors opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.